Search
Descriptor English: Tadalafil
Descriptor Spanish: Tadalafilo
Descriptor tadalafilo
Entry term(s) (6R,12aR)-6-(1,3-benzodioxol-5-il)-2,3,6,7,12,12a-hexahidro-2-metil-pirazino(1',2':1,6)pirido(3,4-b)indol-1,4-diona
Scope note: Derivado de la carbolina e INHIBIDOR DE FOSFODIESTERASA 5 que se utiliza principalmente para tratar la DISFUNCIÓN ERÉCTIL, la HIPERPLASIA PROSTÁTICA BENIGNA y la HIPERTENSIÓN PULMONAR PRIMARIA.
Descriptor Portuguese: Tadalafila
Descriptor French: Tadalafil
Entry term(s): IC-351
IC351
Tree number(s): D03.383.725.150.500
D03.633.100.473.402.111.500
D03.633.300.154.672
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068581
Scope note: A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Vasodilator Agents
Phosphodiesterase 5 Inhibitors
Urological Agents
Registry Number: 742SXX0ICT
CAS Type 1 Name: Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
Related: Citrate de sildénafil MeSH
DeCS ID: 55926
Unique ID: D000068581
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/06
Revision Date: 2019/02/22
Tadalafil - Preferred
Concept UI M0431130
Preferred term Tadalafil
IC-351 - Narrower
Concept UI M0392386
Preferred term IC-351
Entry term(s) IC351



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey